Tag: agile therapeutics

May 22, 2019

Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®

Agile Therapeutics (NASDAQ:AGRX) has announced that the US Food and Drug Administration (FDA) has accepted for review its new drug...
May 17, 2019

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch,

Agile Therapeutics (NASDAQ:AGRX) has announced it has resubmitted to the US Food and Drug Administration (FDA) its new drug application...
January 11, 2019

Agile Therapeutics Provides Regulatory Update and Reiterates Cash Guidance

Agile Therapeutics (Nasdaq:AGRX), a women’s healthcare company, announced that on January 9, 2019 it received final meeting minutes from its...